Custom service

Macrocyclic Peptides Synthesis

Synthesize macrocyclic peptides beyond simple ring closures — staples, thioethers, aryl bridges

Turnaround: 5–9 weeksTypical scale: 0.1 mg – 10 g per sequenceChemistry options: hydrocarbon and aryl-ether bridges; thioether and lactam macrocycles; macrocyclization feasibility screening

Teams come to this service when they need to synthesize macrocyclic peptides beyond simple ring closures — staples, thioethers, aryl bridges. We typically start from hydrocarbon and aryl-ether bridges, add thioether and lactam macrocycles where the application demands it, and close the loop with macrocyclization feasibility screening so the final macrocyclic peptide with topology data behaves consistently across lots.

Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 5–9 weeks timeline holds in practice.

Constrained PPI inhibitors

Macrocycle SAR expansion

Macrocycles requiring transition-metal cross-couplings with no feasibility budget

Sequences where a recombinant expression route is objectively cheaper and faster

Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.

Service Highlights

  • Hydrocarbon and aryl-ether bridges as the default route, with thioether and lactam macrocycles held as a proven fallback
  • Macrocyclization feasibility screening worked into the design where the application requires it
  • Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
  • Analytical confirmation of every intermediate before the final release
  • Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
  • Macrocyclic peptide with topology data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence analysis

    Macrocyclic Peptides Synthesis is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.

  2. Route selection

    Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.

  3. Assembly

    The chain is built with hydrocarbon and aryl-ether bridges applied where the sequence demands it, with double-coupling at hazard sites.

  4. Cleavage & crude QC

    Crude material is characterized so purification targets are set on data, not hope.

  5. Purification

    RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.

  6. Release

    Macrocyclic peptide with topology data is documented with the full analytical package and released.

Specifications & timeline

Turnaround
5–9 weeks
Typical scale
0.1 mg – 10 g per sequence
Chemistry options
hydrocarbon and aryl-ether bridges; thioether and lactam macrocycles; macrocyclization feasibility screening
Deliverable
Macrocyclic peptide with topology data
QC package
HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
Shipping
Ambient with desiccant; blue ice for modified or sensitive peptides

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.